Hook, Hampshire-based TMC Pharma Services, which supports and enables pharma and biotech companies to develop treatments for rare diseases and oncology, has appointed Stewart Sharpe as chief commercial officer.

Sharpe has experience of leading pharma organisations, building teams and launching pharma brands worldwide. He was previously vice-president global commercial lead at Syneos Health, where he led product development and commercialisation.

TMC has appointed Rondeep Bhui as head of strategic planning, joining from Boehringer Ingelheim Vetmedica where he was head of global pharmacovigilance. Bhui has experience in human and veterinary medicines, developing strategic transformation solutions in the areas of pharmacovigilance, regulatory and clinical research.

TMC has appointed Dr Victoria Datsenko as vice-president clinical services, who has more than 20 years’ development experience within global clinical research, covering all clinical trial phases across a broad range of therapies, with particular strength in oncology, cell and gene therapy.

Dr Marcelo Vaz has been appointed head of medical services. Vaz previously led the respiratory group at the biotech unit at ICON, where he developed clinical research expertise across a range of respiratory diseases, including COPD, asthma, IPF and lung cancer.

Julie Matthews, chief executive at TMC, said: “We’re thrilled to be welcoming so many experienced and well-respected healthcare professionals to our team. They each have wide-ranging experience of growing businesses on an international scale and, as we continue to pursue expansion in the USA, Asia and other key global territories, they will be a huge asset in helping us to achieve our goals. Our strong growth over the last year, supported by LDC’s experience and network, has meant we’re well positioned to attract exceptional industry talent and I believe we’ve built the perfect platform to accelerate our international growth as a result.”